Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction

Abstract

It is known that even in spite of timely revascularization of the infarct-related artery, the myocardium in some patients remains hypoperfused. This condition is known as the no-reflow phenomenon, which is associated with an unfavorable prognosis. The systematic review is devoted to the effectiveness of deferred stenting in noreflow prevention. In patients with severe thrombosis, the two-stage revascularization technique is very promising. It is a primary intervention in the form of aspiration thrombectomy and/or balloon angioplasty followed by stenting after a certain period of time. This interval represents a certain therapeutic space, which allows various drugs to act resulting in reduction of blood clot size and risk of procedure-related distal embolization.

Keywords

• acute coronary syndrome
• infarct-related artery
• percutaneous coronary intervention
• no-reflow phenomenon
• myocardial reperfusion
• st-segment elevation myocardial infarction
• no-reflow therapy
• no-reflow prevention
• deferred stenting
• two-stage revascularization